Rivaroxaban Suppresses the Progression of Ischemic Cardiomyopathy in a Murine Model of Diet-Induced Myocardial Infarction

Aim: A direct oral anti-coagulant, FXa inhibitor, has been applied to the clinical treatment of myocardial infarction (MI). Experimental studies in mice indicated that FXa inhibitors reduced atherosclerosis and prevented cardiac dysfunction after coronary ligation. These studies suggested that prote...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Jingyi, Nishida, Makoto, Inui, Hiroyasu, Chang, Jiuyang, Zhu, Yinghong, Kanno, Kotaro, Matsuda, Hibiki, Sairyo, Masami, Okada, Takeshi, Nakaoka, Hajime, Ohama, Tohru, Masuda, Daisaku, Koseki, Masahiro, Yamashita, Shizuya, Sakata, Yasushi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Japan Atherosclerosis Society 2019
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6800390/
https://www.ncbi.nlm.nih.gov/pubmed/30867376
http://dx.doi.org/10.5551/jat.48405

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6800390/
https://www.ncbi.nlm.nih.gov/pubmed/30867376
http://dx.doi.org/10.5551/jat.48405

Ejemplares similares